Sanofi’s Acomplia expects oct 31’06 as the D-day for FDA-approval
French pharmaceutical giant Sanofi-Aventis’s brush with the D-day may soon be knocking at the door. As Sanofi's top brass plan to meet on October 31, 2006 with the financial analysts to report on the company's third quarter earnings, it is believed to be the initial brush with truth as the analyst get ready to be grilled by the U.S. Read More...

Six Chinese held for allegedly marketing fake versions of diet pill Acomplia
China Business News has reported that six representatives of three Chinese pharmaceuticals companies have been detained in Paris, France. Allegedly, they were exhibiting the bulk medicine at a major pharmaceutical tradeshow called CPhI Worldwide 2006. These bulk medicines were suspected to become a black-market version of Acomplia (rimonabant). Read More...

Diet Drug "Acomplia" hit the headlines
The news that's creating vibes all around is the WebMD's report that appeard online in the Cochrane Library. It reveals that only higher dose of Acomplia results in significant weight loss,the lower trial dose has been abandoned since long and even reducing the diet intake by 600 calories doesn't help. Read More...

Acomplia gets rising hope from Aetna
Even after not having any meeting scheduled with FDA Advisory panel Acomplia is getting good reviews from known persons in the medicine industry. On 12th October chief pharmacist of Aetna inc. which is indulged in providing a big part of prescription drugs in the medicine market has said that he have very optimistic approach Read More...

Diet Drug Acomplia approval could be delayed for 2007
An updated schedule for FDA advisory committee meeting has been posted on 10th October and the thing which needs to notice is that there is no sign that the panel will have any meeting with Sanofi regarding the approval of Acomplia drug in US in 2006. It was stated before that there is a hope that Rimonabant will get approval in 2006 itself. Read More...

FDA has not asked for acomplia performance data
On Oct. 6 Sanofi-Aventis had denied that FDA has asked for more safety data which was gathered by Sanofi to track the side effects of diet drug Acomplia in Europe .This data can be helpful to approve the diet-pill for sale in the United States. Read More...

Diet drug acomplia launched in more EU countries and still hoped for US launch in 2006
On October 5th Sanofi-Aventis has declared that the diet pill Acomplia will be continuing in Europe. The diet drug is now also available in seven European countries.. Read More...

Sanofi decided to be Silent till 31st October
A note has been sent by a research analyst stating that Sanofi is silent to most investors, analysts and the media. It will remain quiet until it announces its quarterly financial results on October 31. Read More...

Merk trials on diet drug similar to Acomplia continues
Merck’s another diet drug has got dissatisfying results from its trials but Phase II results are still continued on large basis considering this drug similar to the drug pending for approval from FDA which is Acomplia. Read More...